<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Vivos Therapeutics Inc.</title><link>https://investorshangout.com/Vivos-Therapeutics-Inc-VVOS-94176/</link><description><![CDATA[Vivos Therapeutics Inc. (VVOS)]]></description><language>en-us</language><pubDate>Wed, 02 Sep 2026 04:47:07 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Vivos-Therapeutics-Inc-VVOS-94176/" rel="self" type="application/rss+xml"/><item><title>Golden Cross: $VVOS Vivos Therapeutics Expands AI Workflow Partnership with Greenway Health, Citing Up to $9.1 Mil</title><link>https://investorshangout.com/post/view?id=6840370</link><guid>https://investorshangout.com/post/view?id=6840370</guid><description><![CDATA[Golden Cross
]]></description><pubDate>Tue, 11 Aug 2026 14:43:59 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, FY 2023 Financial Report,</title><link>https://investorshangout.com/post/view?id=6681547</link><guid>https://investorshangout.com/post/view?id=6681547</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 01 Apr 2024 20:33:58 GMT</pubDate></item><item><title>znewcar1: $VVOS 64% v249M c.3045 f29,928M Hod.4498 Eod Flush to .3 strong aft</title><link>https://investorshangout.com/post/view?id=6626756</link><guid>https://investorshangout.com/post/view?id=6626756</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 04 Oct 2023 22:47:34 GMT</pubDate></item><item><title>znewcar1: $VVOS hod2.15 does it BO2.96 YH? 2.32 should be critical.</title><link>https://investorshangout.com/post/view?id=6519120</link><guid>https://investorshangout.com/post/view?id=6519120</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 05 Jan 2023 20:39:57 GMT</pubDate></item><item><title>znewcar1: $VVOS 154% v112,3M c1.88 f23,012M H2.96 GapChopNgo</title><link>https://investorshangout.com/post/view?id=6518598</link><guid>https://investorshangout.com/post/view?id=6518598</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 04 Jan 2023 21:02:17 GMT</pubDate></item><item><title>znewcar1: $VVOS hod2.93</title><link>https://investorshangout.com/post/view?id=6518369</link><guid>https://investorshangout.com/post/view?id=6518369</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 04 Jan 2023 15:28:13 GMT</pubDate></item><item><title>znewcar1: $VVOS morning gapper w/v21.3M pmh1.94 ML.34 anyone going to trade this?</title><link>https://investorshangout.com/post/view?id=6518290</link><guid>https://investorshangout.com/post/view?id=6518290</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 04 Jan 2023 14:23:55 GMT</pubDate></item><item><title>NetworkNewsWire: New Study Backs Benefits of CPAP Therapy for OSA Obstructive sleep apnea (“OSA”) is a chro</title><link>https://investorshangout.com/post/view?id=6292923</link><guid>https://investorshangout.com/post/view?id=6292923</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 01 Dec 2021 21:45:52 GMT</pubDate></item><item><title>NetworkNewsWire: Study Explores Link Between Obstructive Sleep Apnea and COVID-19 Obstructive sleep apnea (</title><link>https://investorshangout.com/post/view?id=6286418</link><guid>https://investorshangout.com/post/view?id=6286418</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 18 Nov 2021 21:46:07 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q3 2021 Financial, Operationa</title><link>https://investorshangout.com/post/view?id=6284636</link><guid>https://investorshangout.com/post/view?id=6284636</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 16 Nov 2021 19:47:44 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation at Q4 Virtual </title><link>https://investorshangout.com/post/view?id=6283770</link><guid>https://investorshangout.com/post/view?id=6283770</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 15 Nov 2021 20:01:01 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Scheduled Release of Q3 2021</title><link>https://investorshangout.com/post/view?id=6280256</link><guid>https://investorshangout.com/post/view?id=6280256</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 09 Nov 2021 19:40:05 GMT</pubDate></item><item><title>NetworkNewsWire: Obstructive Sleep Apnea May Be Affecting Productivity in Workplace The National Institutes</title><link>https://investorshangout.com/post/view?id=6273524</link><guid>https://investorshangout.com/post/view?id=6273524</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 29 Oct 2021 23:40:37 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Global Small Ca</title><link>https://investorshangout.com/post/view?id=6268385</link><guid>https://investorshangout.com/post/view?id=6268385</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 22 Oct 2021 19:28:04 GMT</pubDate></item><item><title>NetworkNewsWire: OSA Predisposes People to Metabolic Defects, Study Finds Obstructive sleep apnea (“OSA”) p</title><link>https://investorshangout.com/post/view?id=6267588</link><guid>https://investorshangout.com/post/view?id=6267588</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 21 Oct 2021 21:09:23 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Showcasing Innovations in OSA Treatmen</title><link>https://investorshangout.com/post/view?id=6266795</link><guid>https://investorshangout.com/post/view?id=6266795</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 20 Oct 2021 21:09:21 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS), Candid to Bring Airway and Sleep, Ora</title><link>https://investorshangout.com/post/view?id=6265769</link><guid>https://investorshangout.com/post/view?id=6265769</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 19 Oct 2021 20:04:14 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS), Candid Collaborate to Deliver Compreh</title><link>https://investorshangout.com/post/view?id=6264813</link><guid>https://investorshangout.com/post/view?id=6264813</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 18 Oct 2021 19:56:30 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc.’s (NASDAQ: VVOS) Guides Demonstrate Significant Reduc</title><link>https://investorshangout.com/post/view?id=6261954</link><guid>https://investorshangout.com/post/view?id=6261954</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 13 Oct 2021 19:16:40 GMT</pubDate></item><item><title>NetworkNewsWire: Sleep Apnea More Prevalent Among Children, Can Impact Grades Nemours Children’s Health dir</title><link>https://investorshangout.com/post/view?id=6256973</link><guid>https://investorshangout.com/post/view?id=6256973</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 06 Oct 2021 20:50:48 GMT</pubDate></item><item><title>NetworkNewsWire: What to Know About At-Home Sleep Apnea Tests When one is asleep, the body’s muscles, which</title><link>https://investorshangout.com/post/view?id=6247811</link><guid>https://investorshangout.com/post/view?id=6247811</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 23 Sep 2021 21:36:08 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Forms Medical Consortium to Advance OS</title><link>https://investorshangout.com/post/view?id=6247766</link><guid>https://investorshangout.com/post/view?id=6247766</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 23 Sep 2021 20:47:49 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Healthcare Smal</title><link>https://investorshangout.com/post/view?id=6246638</link><guid>https://investorshangout.com/post/view?id=6246638</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 22 Sep 2021 19:21:23 GMT</pubDate></item><item><title>NetworkNewsWire: Four Lifestyle Changes That May Benefit Individuals with Sleep Apnea Sleep apnea is a comm</title><link>https://investorshangout.com/post/view?id=6237713</link><guid>https://investorshangout.com/post/view?id=6237713</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 10 Sep 2021 21:29:22 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Participate at H.C. Wainwright 23rd</title><link>https://investorshangout.com/post/view?id=6235367</link><guid>https://investorshangout.com/post/view?id=6235367</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 08 Sep 2021 20:41:19 GMT</pubDate></item><item><title>NetworkNewsWire: Study Finds That Sleep Apnea Increases Risk of Sudden Death Research conducted by Penn Sta</title><link>https://investorshangout.com/post/view?id=6226883</link><guid>https://investorshangout.com/post/view?id=6226883</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 27 Aug 2021 20:44:56 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Partners with Empower Sleep in Effort </title><link>https://investorshangout.com/post/view?id=6225854</link><guid>https://investorshangout.com/post/view?id=6225854</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 26 Aug 2021 20:16:42 GMT</pubDate></item><item><title>znewcar1: VVOS 53% V172m C5.90 F22,8m h7.09 s5.3 late EOD pop to 6.84 failed</title><link>https://investorshangout.com/post/view?id=6222519</link><guid>https://investorshangout.com/post/view?id=6222519</guid><description><![CDATA[znewcar1
]]></description><pubDate>Mon, 23 Aug 2021 22:22:11 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Receives FDA Clearance for mmRNA Oral </title><link>https://investorshangout.com/post/view?id=6222465</link><guid>https://investorshangout.com/post/view?id=6222465</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 23 Aug 2021 20:19:10 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Detailed Summary of National </title><link>https://investorshangout.com/post/view?id=6218467</link><guid>https://investorshangout.com/post/view?id=6218467</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 18 Aug 2021 21:17:54 GMT</pubDate></item><item><title>NetworkNewsWire: Less TV, More Physical Exercise Reduces Sleep Apnea Risks According to a new study, people</title><link>https://investorshangout.com/post/view?id=6217443</link><guid>https://investorshangout.com/post/view?id=6217443</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 17 Aug 2021 21:59:06 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q2 2021 Financial, Operationa</title><link>https://investorshangout.com/post/view?id=6214498</link><guid>https://investorshangout.com/post/view?id=6214498</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 13 Aug 2021 23:19:15 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation in Q3 Virtual </title><link>https://investorshangout.com/post/view?id=6211058</link><guid>https://investorshangout.com/post/view?id=6211058</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 10 Aug 2021 19:18:09 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Conference Call to Discuss Q</title><link>https://investorshangout.com/post/view?id=6210187</link><guid>https://investorshangout.com/post/view?id=6210187</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 09 Aug 2021 21:07:10 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Opening of Denver-Based Stat</title><link>https://investorshangout.com/post/view?id=6201088</link><guid>https://investorshangout.com/post/view?id=6201088</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 29 Jul 2021 19:49:34 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Promising Study Results for </title><link>https://investorshangout.com/post/view?id=6183892</link><guid>https://investorshangout.com/post/view?id=6183892</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 13 Jul 2021 20:14:24 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Unveils Study Data Showing 97% of Vivo</title><link>https://investorshangout.com/post/view?id=6177808</link><guid>https://investorshangout.com/post/view?id=6177808</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 07 Jul 2021 19:10:07 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc.’s (NASDAQ: VVOS) Strides in Treatment Innovation High</title><link>https://investorshangout.com/post/view?id=6173458</link><guid>https://investorshangout.com/post/view?id=6173458</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 01 Jul 2021 19:57:27 GMT</pubDate></item><item><title>NetworkNewsWire: Vivos Therapeutics Inc. (NASDAQ: VVOS) Founder and Chief Medical Officer Shares Company’s Groundb</title><link>https://investorshangout.com/post/view?id=6169020</link><guid>https://investorshangout.com/post/view?id=6169020</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 25 Jun 2021 20:01:58 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) CEO Discusses Unique System That Rebui</title><link>https://investorshangout.com/post/view?id=6156447</link><guid>https://investorshangout.com/post/view?id=6156447</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 09 Jun 2021 21:05:08 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Founder, CEO Authors Book Focused on G</title><link>https://investorshangout.com/post/view?id=6145968</link><guid>https://investorshangout.com/post/view?id=6145968</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 26 May 2021 20:24:34 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Appoints Widely Acclaimed Leader as Ne</title><link>https://investorshangout.com/post/view?id=6108819</link><guid>https://investorshangout.com/post/view?id=6108819</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 14 Apr 2021 19:45:56 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation in Upcoming Em</title><link>https://investorshangout.com/post/view?id=6106546</link><guid>https://investorshangout.com/post/view?id=6106546</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 12 Apr 2021 21:01:45 GMT</pubDate></item><item><title>znewcar1: VVOS 27% v2,4M c9.35 f17,5M H10.1</title><link>https://investorshangout.com/post/view?id=6100172</link><guid>https://investorshangout.com/post/view?id=6100172</guid><description><![CDATA[znewcar1
]]></description><pubDate>Mon, 05 Apr 2021 20:49:53 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Unveils New MyoCorrect Orofacial Myofu</title><link>https://investorshangout.com/post/view?id=6096041</link><guid>https://investorshangout.com/post/view?id=6096041</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 30 Mar 2021 20:15:44 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, FY 2020 Financial, Operat</title><link>https://investorshangout.com/post/view?id=6093233</link><guid>https://investorshangout.com/post/view?id=6093233</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Fri, 26 Mar 2021 22:11:13 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Present at Benzinga Biotech Confere</title><link>https://investorshangout.com/post/view?id=6089694</link><guid>https://investorshangout.com/post/view?id=6089694</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Tue, 23 Mar 2021 21:31:57 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Conference Call to Release, </title><link>https://investorshangout.com/post/view?id=6085787</link><guid>https://investorshangout.com/post/view?id=6085787</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Thu, 18 Mar 2021 20:06:09 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces FDA 510(k) Application for E</title><link>https://investorshangout.com/post/view?id=6079986</link><guid>https://investorshangout.com/post/view?id=6079986</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Wed, 10 Mar 2021 21:59:10 GMT</pubDate></item><item><title>NetworkNewsWire: NetworkNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Opens First-Ever Pneusomnia Clinic, Un</title><link>https://investorshangout.com/post/view?id=6077188</link><guid>https://investorshangout.com/post/view?id=6077188</guid><description><![CDATA[NetworkNewsWire
]]></description><pubDate>Mon, 08 Mar 2021 20:24:03 GMT</pubDate></item></channel></rss>